Cytosorbents Corporation (CTSO) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Cytosorbents Corporation (CTSO) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $35.8M, listed on NASDAQ, employing roughly 149 people, carrying a beta of 1.44 to the broader market. Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Led by Phillip Chan, public since 2006-08-08.
Snapshot as of May 15, 2026.
- Spot Price
- $0.50
- Total OI
- 153